Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
This is a MONSTER stock at the right time. Q4 and then Q1 is going to make IDRA double or triple. Baker Brothers own a lot at 3.65. Here is some good info on it~ http://seekingalpha.com/article/3099106-idera-pharmaceuticals-is-the-writing-on-the-wall
This is a scam stock that insiders use for a piggy bank. Ask anyone who investor because of Barry, the ex investor relations.
Thanks for the update on Barry. He has no conscience to hurt new investors. For those still invested in UPPR, DO NOT SELL in blocks bigger than 1000 shares. You will get more $ out of it then selling in larger blocks. I was an early investor and learned that process to recover a little more $.
Barry's other stocks are STOY and PTPF that I am aware of. Blessing to all that have been hurt by Barry.
Beware if Barry got you in this stock. He is a scam artist.
BEWARE OF BARRY AT INVESTOR RELATIONS FOR TRTC, HE IS A SCAM ARTIST. Pull his covers by putting out warnings to everyone on the internet. It will ruin his ability to work in the industry scamming retail investors. I am down to help, you can find me on Facebook Glenn Langohr
BEWARE OF BARRY AT INVESTOR RELATIONS. No volume equals, can't sell, scam stock.
BEWARE OF BARRY AT INVESTOR RELATIONS FOR TRTC. He is a thief and a fraud. The only way to make your $ back is to short stocks he is involved in at their highs.
What the future holds for SYN
Lets lay out all of the catalysts from now until Q1 of 2016. We got two phase 2a trials for SYN-004, phase 2a-1 trial results in September, phase 2a-2 results in December.
We have two phase 2 trials for SYN-010, phase 2-1 trial results in September, phase 2-2 results in December. Then my guess is fast track/QIDP status will be granted to SYN-004 if both phase 2a trials are positive. FDA is very desperate for a C-diff preventative or treatment (if I were them, I'd rather have the preventative), so they want to get SYN-004 to market as fast as possible. And we will also be getting SYN-004 phase 2b interim results in December.
My guess is we will get a Trimesta partner by end of 2015, as Liz and many others have mentioned, there is no timeline. No clue as to when we get the MRI data. But go look at post #975 written by Liz, and that will give you a good idea of what the MRI data will show.
We should also get an update on the P2A drug, which is currently being tested in a pig microbiome. Between all of those catalysts, I bet our pps will be somewhere in the 8-12 range. I don't think we will have to raise until at least Q2 of 2016, maybe later depending on the amount of funding from the Trimesta partner. The future for SYN is very bright, and if they have to dilute, so what? They are a small cap bios, get over it. All small cap bios have to dilute every now and then. As long as XON keeps taking shares as payment for the PKU, that is all I need to know to keep me invested. Here's to a good Fall and Winter for SYN, and I personally believe SYN will become one of the largest cap biotechs in the market over the next 15-20 years if they don't get gobbled up by a big pharma, you just have to be patient. Do your own DD, and don't let the bashers get to you. GLTAL
PTPF now trades as PTPFE. I have been in this stock for over a year. It trades at around .50 when they get any volume. I could have traded out of it at .65 but thought it was going higher. So if you get in now at these prices you can make some good $ once they pump it again.
It looks like the next stock they are going to pump is PTPFE. If you get in early you might make some good $.
STOY IS A SCAM PUMP AND DUMP. Barry from investor relations at TRTC will steal all your money by telling you to put it in STOY or UPPR or whatever new stock his insiders are selling as you buy.
Up BIG PRE MARKET: New Analyst coverage (Average Price Target is 8.33): BTIG Starts Synthetic Biologics (SYN) at Buy
7:39 AM ET, 08/25/2015 - StreetInsider
BTIG initiated coverage on Synthetic Biologics (NYSE: SYN) with a Buy rating and a price target of $5.
Analyst Timothy Chiang said, "Synthetic Biologics is a clinical stage co. developing products to protect the microbiome. Drugs being evaluated include SYN-010 (modified-release lovastatin the treatment of IBS-c), and SYN-004 (a 2nd generation oral enzyme for the prevention of C. difficile infection and antibiotic associated diarrhea [AAD]). Both of these candidates have recently entered Ph. 2 trials, with readouts expected in late Q4/early Q1. We assign $3/share of the SYN s valuation to the IBS-C program, and $2/share to the co s beta lactamase enzyme for the prevention of C. difficile. SYN recently hired Dr. Klaus Gottlieb, a former FDA reviewer for the GI division, as VP, Clinical Affairs. We believe this addition could improve the SYN s odds of successfully developing SYN-010 and ultimately obtaining FDA approval, which we estimate could occur by 2019."
For an analyst ratings summary and ratings history on Synthetic Biologics click here. For more ratings news on Synthetic Biologics click here.
Shares of Synthetic Biologics closed at $2.17 yesterday.
https://www.tipranks.com/stocks/sngx STRONG BUY, INSIDERS PURCHASES LAST 3 MONTHS, 5 PRICE TARGET
https://www.tipranks.com/stocks/syn Says SYN is a STRONG BUY, 285% upside.
Beware STOCK SCAM, this is a pump and dump. It is a better short on pops.
As mentioned, billionaire biotech investor/expert R.J. Kirk owns 49% of SNGX and his other stocks like XON, ZIOP, FCSC, SYN and OGEN have tripled this year.
SNGX has a robust pipeline so this has a LOT OF PR that can triple the price of this stock as well:
Soligenix announces that the National Institute of Allergy and Infectious Diseases has exercised its option to advance the development of Soligenix's heat stabilized ricin toxin vaccine RiVax
7:00 AM ET, 08/19/2015 - Briefing.com
The overall objectives of the contract are to advance the development of Soligenix's thermostabilization technology, ThermoVax, combined with the company's ricin toxin vaccine, RiVax, as a medical countermeasure to prevent the effects of ricin exposure.
The exercised option will provide Soligenix with an additional $2.7 million in funding. If all contract options are exercised, the total award of up to $24.7 million will support the preclinical, manufacturing and clinical development activities necessary to advance heat stable RiVax with the US Food and Drug Administration (FDA).
The Pump and Dump Stoy round 2 or 3? LOL
Just bought a GRIP OF SYN (Tripled my existing position.
You might remember I said I bought a grip of SYN right after last earnings at 2.00. I am sold on the pipeline and BOD with Riley and Klaus Gottlieb's experience with the FDA and Fortune 500 company getting similar drugs to market from PH III.
The confidence in Riley's CC, coupled with the increased PR we saw last time after earnings...
Don't we have an FDA QIDP Fast Track Coming? Can you experts weigh in on if this application has already been in the works?
THANKS
If you want to follow a real PRO go to investor village and follow Rob Cos's picks. The dude is the best by far. You can also find his DD on seeking alpha under biothoughts. His main picks are XON ZIOP FCSC SYN HALO and CRMD. GLTA
Thanks for the JBEM email. He is probably buying this dip. I don't trust his motives. I'm in this stock at just over 1.50 for the pipeline depth which equals PR. I can wait. I'm not adding down here because I'm far enough into it, but would if I wasn't. I watched this stock go up to $3 in January and it will do the same thing next January if we don't get there before. I'm in because R.J. Kirk owns a bunch also.
Can someone copy and paste the email JBEM sent that supposedly is crashing this stock. If you are in this stock, you have to know that volume isn't much, which means any selling causes this drop. Just like any buying increases it the same way. It isn't a day trade it is a buy and hold.
Where is this email? thanks
I expect more analyst coverage to start for SNGX with this second Orphan Drug designation. This reminds me of FCSC who also got a second Orphan drug designation and also has R.J. Kirk involved. Orphan drug designation by the FED makes it a huge takeout target from big pharma due to exclusivity... LONG every R.J. Kirk stock including SNGX! Patient investors will double or triple from here.
More than doubled my position at 1.47. Easy double from here. Lots of news coming between now and December. Easy $ to buy R.J. Kirk stocks. I play XON, ZIOP, FCSC and SYN, SNGX is my bottom feeder. GLTA
I agree that a friday ATM is a red flag, but this is an OTC stock where $ and volume is hard to raise. I have a small investment at 1.65 and knew it could go to 1.50 area to add more. The reason this investment WILL make $ is because they have a large and explosive pipeline (even if it is fraudulent) news will still come out that pops the price. Every January through March this stock goes to $3. Having R.J. Kirk invested brings a lot of people on dips. So longs, add to your position to price down if it goes to 1.50 or lower. It won't stay there long. Expect a lot of PR from between now and November and then bail until December lows and reenter.
Billionaire biotech guru R.J. Kirk who runs XON and Third Security, owns 36% of SYN. SYN is headed to $10 this year I'm thinking.
So glad I got to buy SYN on the cheap today! Rode it from 2.00 to 2.75 and had to watch it fly without me. I knew they needed cash so I pulled profits. R.J. Kirk and XON own 36% of SYN and 004 news coming, Trimesta deal, plus R.J. Kirk/XON might have just added on this secondary. If that is the case in the filings, we surge even higher. There isn't another biotech on my list with as much near term double/triple potential and I have almost all R.J. Kirk Stocks: XON/ZIOP FCSC, SNGX
Jbem777 anyway to follow what you are doing besides ihub? my email is rollcallthebook@gmail.com and Facebook is author glenn langohr thanks
BEWARE Barry at Investor Relations for TRTC Tells You to Invest in other pump and dump stocks. What does that tell you about TRTC. Short TRTC all year and buy back in late December. Way better stocks out there.
This is a fake company, they don't even have product to sell, the phone number to buy the product is the proof. Pump and dump scam. Won't even be around and trading soon.
I bought big in this stock because XON R.J. Kirk is now involved. He is the smartest Bio Investor out there and all his stocks eventually turn to Gold. This article also helpedhttp://seekingalpha.com/article/3068386-our-2-healthcare-picks-for-april It is a good time to be invested in SYN with a lot of catalysts coming that can equate to a massive run.
This stock is almost done being pumped and dumped. It won't even be trading soon so Beware of this SCAM and don't lose all your money.
STOY doesn't even sell toys. It is a scam stock Pump and Dump. Get your $ out before you lose it all when the volume dies.
Pump and dump scam. Beware of shrinking volume and the bid ask separation. Signs that mean bad things to come.
Pump and Dump Stock be careful you don't lose all your $ won't even be around next year
TRTC is done. Longs are drinking the bong water. All insider selling and toxic lending Total scam.
Total scam stock, won't even be around or any trading volume. Already pumped a few times. One of the better pumpers notified all their customers that the STOY phone # on their youtube video didn't even work.
Total Scam stock pump and dump, Buyer Beware
AND...THE DUMP Get your money out before the volume dies and so does your $$$
Total Scam stock. Better get your $ out before you lose it.
Already pumped and dumped once. This is round 2. Scam stock